<p>Tharimmune Inc. has filed an initial statement of beneficial ownership (Form 3) with the U.S. Securities and Exchange Commission. The filing names Mark Christopher Toomey as the beneficial owner, who serves as President of the company. The full filing can be accessed through the link below. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Tharimmune Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001493152-25-023307), on November 14, 2025, and is solely responsible for the information contained therein. © Copyright 2025 - Public Technologies (PUBT) Original Document: here</p>

THAR

<p>Tharimmune Inc. has filed a Form 3 with the U.S. SEC, naming President Mark Christopher Toomey as the beneficial owner. This filing is accessible via EDGAR. The information is for informational purposes and not financial advice.</p>

Tharimmune Inc. Files Initial Statement of Beneficial Ownership for President Mark Toomey